Vanguard Group Inc Rigel Pharmaceuticals Inc Transaction History

Vanguard Group Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.12 - $1.57 $463,911 - $650,304	414,207 Added 4.63%	9,367,424 $13.9 Million
Q4 2023 Feb 14, 2024	BUY	$0.72 - $1.56 $61,536 - $133,328	85,467 Added 0.96%	8,953,217 $13 Million
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.39 $2.21 Million - $2.88 Million	-2,069,079 Reduced 18.92%	8,867,750 $9.58 Million
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.82 $472,980 - $768,593	-422,304 Reduced 3.72%	10,936,829 $14.1 Million
Q1 2023 May 15, 2023	SELL	$1.25 - $2.0 $905,828 - $1.45 Million	-724,663 Reduced 6.0%	11,359,133 $15 Million
Q4 2022 Feb 10, 2023	BUY	$0.67 - $11.9 $94,872 - $1.69 Million	141,600 Added 1.19%	12,083,796 $18.1 Million
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $1.61 Million - $17.8 Million	1,463,026 Added 13.96%	11,942,196 $14.1 Million
Q2 2022 Aug 12, 2022	BUY	$0.67 - $3.19 $902,463 - $4.3 Million	1,346,960 Added 14.75%	10,479,170 $11.8 Million
Q1 2022 May 13, 2022	BUY	$2.22 - $3.45 $231,093 - $359,131	104,096 Added 1.15%	9,132,210 $27.3 Million
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $130,128 - $196,846	-55,139 Reduced 0.61%	9,028,114 $23.9 Million
Q3 2021 Nov 12, 2021	BUY	$3.5 - $4.5 $24,993 - $32,134	7,141 Added 0.08%	9,083,253 $33 Million
Q2 2021 Aug 13, 2021	BUY	$3.09 - $4.54 $28 Million - $41.2 Million	9,076,112 New	9,076,112 $39.4 Million

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.